Lin, A., Shah, K. A., Sharma, J., Shum, E., Sabari, J. K. (2026). Association of MET overexpression with patient outcomes in
                    <i>EGFR</i>
                    -mutant lung adenocarcinoma treated with first-line osimertinib.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20757